Tolllike receptor 7/8 agonist, R848, exhibits antitumoral effects in a breast cancer model

Author：

E-ISSN： 1791-3004|12|3|3515-3520

ISSN： 1791-2997

Source： Molecular Medicine Reports, Vol.12, Iss.3, 2015-01, pp. : 3515-3520

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

NK1.1 + cells mediate the antitumor effects of a dual Toll-like receptor 7/8 agonist in the disseminated B16-F10 melanoma model

By Dumitru Calin

Cancer Immunology, Immunotherapy, Vol. 58, Iss. 4, 2009-04 ,pp. : 575-587

Springer Publishing Company

Access to resources Recommend Favorite

Immunotherapeutic Impact of Toll-like Receptor Agonists in Breast Cancer

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 15, Iss. 9, 2015-01 ,pp. : 1134-1140

Bentham Science Publishers

Access to resources Recommend Favorite

DMSO exhibits similar cytotoxicity effects to thalidomide in mouse breast cancer cells

Oncology Letters, Vol. 3, Iss. 4, 2012-01 ,pp. : 927-929

Spandidos Publications

Access to resources Recommend Favorite

New Perspective Therapy of Breast Cancer Based on Selective Dopamine Receptor D2 Agonist and Antagonist Effects on MCF-7 Cell Line

Recent Patents on Anti-Cancer Drug Discovery, Vol. 10, Iss. 2, 2015-05 ,pp. : 214-223

Bentham Science Publishers

Access to resources Recommend Favorite

Downregulation of survivin expression exerts antitumoral effects on mouse breast cancer cells in vitro and in vivo

Oncology Letters, Vol. 11, Iss. 1, 2016-01 ,pp. : 159-167

Spandidos Publications

Access to resources Recommend Favorite